Cargando…
ATDC Mediates a TP63-Regulated Basal Cancer Invasive Program
Basal subtype cancers are deadly malignancies but the molecular events driving tumor lethality are not completely understood. Ataxia-Telangiectasia Group D Complementing gene (ATDC, also known as TRIM29), is highly expressed and drives tumor formation and invasion in human bladder cancers but the fa...
Autores principales: | Palmbos, Phillip L., Wang, Yin, Bankhead, Armand, Kelleher, Alan J., Wang, Lidong, Yang, Huibin, Ahmet, McKenzie L., Gumkowski, Erica R., Welling, Samuel D., Magnuson, Brian, Leflein, Jacob, Hiles, Guadalupe Lorenzatti, Abel, Ethan, Dziubinski, Michele L., Urs, Sumithra, Day, Mark, Ljungman, Mats E., Simeone, Diane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499660/ https://www.ncbi.nlm.nih.gov/pubmed/30643195 http://dx.doi.org/10.1038/s41388-018-0646-9 |
Ejemplares similares
-
ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis
por: Wang, Lidong, et al.
Publicado: (2015) -
TP63 isoform expression is linked with distinct clinical outcomes in cancer
por: Bankhead, Armand, et al.
Publicado: (2020) -
ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis
por: Wang, Lidong, et al.
Publicado: (2019) -
ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer
por: Purohit, Vinee, et al.
Publicado: (2021) -
HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties
por: Abel, Ethan V, et al.
Publicado: (2018)